Neurotechnologies combine neuroscience and engineering to build tools for studying, repairing, and augmenting the brain and other physiological functions. These include brain-computer interfaces (BCIs) - typically used as assistive devices and, more recently, as human enhancement devices - neural prosthetics, optogenetics, digital medicine, continuous remote monitoring, drugs, and other pharmaceutical interventions.
While traditionally BCIs have been readily available in research labs for almost half a century, the last decade has experienced a significant growth in the number of companies and applied research labs aiming at bringing them to the market. Yet, several challenges have to be solved to demonstrate the technological readiness and marketability of BCIs. The technological transfer cycle is still at the beginning of its life span, and effort must be made into closing the loop between product development and BCI research coming out of the lab. Accelerating BCI's time-to-market is key to transfer academic novelty into market impact and vice-versa.
The goal of this Research Topic is to showcase the bidirectional interaction between academic labs and industry partners and inform the community and the general public about recent advances in translational work of BCIs. We call for submissions from both academic labs and industry R&D departments that describe and showcase applied research towards the development of novel BCIs for clinical, business-to-business and consumer markets.
We welcome submissions in any area of applied BCIs. These include, but are not limited to:
• Invasive and non-invasive neural recordings or brain stimulation
• Passive / active, open-loop / closed-loop BCIs, with or without real-time neurofeedback
• Hybrid BCIs combining any recording from or stimulation to cortical neuronal activity with other physiological measures, such as galvanic skin response (GSR), electrooculography (EOG), electromyography (EMG), heart rate monitoring (HR)
• Hybrid BCIs or systems to create complete solutions, such as eye tracking, motion tracking, or other ambient sensors like microphone, cameras, or stimulators, such as visuals, haptics
• Novel neuroergonomics and clinical applications of BCIs
In every submission, the current or potential user should be clearly defined.
We also encourage contributions from neurotechnology investors, to describe recent trends and future prospects of this market.
Submissions can be any article type, and we particularly encourage Original Research, Review, Clinical Trial, and Perspective articles.
Topic Editor Dr. Davide Valeriani is employed by Neurable Inc.
Topic Editor Dr. Antonia Thelen is employed by eemagine GmbH.
All other Topic Editors declare no competing conflicts of interest.
Neurotechnologies combine neuroscience and engineering to build tools for studying, repairing, and augmenting the brain and other physiological functions. These include brain-computer interfaces (BCIs) - typically used as assistive devices and, more recently, as human enhancement devices - neural prosthetics, optogenetics, digital medicine, continuous remote monitoring, drugs, and other pharmaceutical interventions.
While traditionally BCIs have been readily available in research labs for almost half a century, the last decade has experienced a significant growth in the number of companies and applied research labs aiming at bringing them to the market. Yet, several challenges have to be solved to demonstrate the technological readiness and marketability of BCIs. The technological transfer cycle is still at the beginning of its life span, and effort must be made into closing the loop between product development and BCI research coming out of the lab. Accelerating BCI's time-to-market is key to transfer academic novelty into market impact and vice-versa.
The goal of this Research Topic is to showcase the bidirectional interaction between academic labs and industry partners and inform the community and the general public about recent advances in translational work of BCIs. We call for submissions from both academic labs and industry R&D departments that describe and showcase applied research towards the development of novel BCIs for clinical, business-to-business and consumer markets.
We welcome submissions in any area of applied BCIs. These include, but are not limited to:
• Invasive and non-invasive neural recordings or brain stimulation
• Passive / active, open-loop / closed-loop BCIs, with or without real-time neurofeedback
• Hybrid BCIs combining any recording from or stimulation to cortical neuronal activity with other physiological measures, such as galvanic skin response (GSR), electrooculography (EOG), electromyography (EMG), heart rate monitoring (HR)
• Hybrid BCIs or systems to create complete solutions, such as eye tracking, motion tracking, or other ambient sensors like microphone, cameras, or stimulators, such as visuals, haptics
• Novel neuroergonomics and clinical applications of BCIs
In every submission, the current or potential user should be clearly defined.
We also encourage contributions from neurotechnology investors, to describe recent trends and future prospects of this market.
Submissions can be any article type, and we particularly encourage Original Research, Review, Clinical Trial, and Perspective articles.
Topic Editor Dr. Davide Valeriani is employed by Neurable Inc.
Topic Editor Dr. Antonia Thelen is employed by eemagine GmbH.
All other Topic Editors declare no competing conflicts of interest.
